Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-12

Clinical Trial Update: Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating blood glucose response after ingesting lactulose in patients with type 2 diabetes and mild constipation; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LACTULOSE (Lactulose)

Snippet

Sponsor: Fresenius Kabi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED